INNOGEN-B (02591.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec10

Yinnuovo-B (2591) triggered the market volatility control mechanism due to significant price fluctuations.

02:29

Dec8

Innocare Pharma is officially included in the Stock Connect on December 8, but its stock price fell sharply on the first day

01:30

Silver No Pharmaceutical's Core Product Included in National Medical Insurance Drug List

00:57

Dec1

Sinornovate Biopharm-B and its wholly-owned subsidiary purchase structured deposit product from Ningbo Bank

12:36

Nov24

InnoCare Pharma-B (2591.HK) stock price surged over 19% after being included in the Hang Seng Composite Index

01:30

Nov21

Innogen-B (2591.HK) announced the postponement of the transition of its Board of Directors and Supervisory Committee.

17:40

Schedules & Filings

Schedules

Filings

Aug29

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 30.89 M, Net Income -67.02 M, EPS -0.1594

Aug15

IPO(CST)

Listing Price HKD 18.68

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More